Aptevo Therapeutics (APVO) News Today $0.23 -0.01 (-6.18%) (As of 10:16 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Aptevo Therapeutics (NASDAQ:APVO) Coverage Initiated at StockNews.comNovember 15 at 3:19 AM | americanbankingnews.comAptevo Therapeutics Inc. (NASDAQ:APVO) Sees Significant Increase in Short InterestNovember 14 at 4:01 AM | americanbankingnews.comAptevo Therapeutics: First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor TrialNovember 12 at 7:38 PM | finanznachrichten.deWhat is Roth Capital's Forecast for APVO Q1 Earnings?November 11, 2024 | americanbankingnews.comAptevo Therapeutics (NASDAQ:APVO) Research Coverage Started at StockNews.comNovember 10, 2024 | americanbankingnews.comAptevo Therapeutics (NASDAQ:APVO) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comAptevo Therapeutics (NASDAQ:APVO) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comClinuvel Pharmaceuticals Limited (UR9.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.comAptevo Therapeutics: Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia Trial InitiatedAugust 13, 2024 | finanznachrichten.deBiotech Seeing Significant Buying Pressure Before The Opening BellJuly 19, 2024 | theglobeandmail.comAPVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q1 2024May 8, 2024 | investorplace.comWhy Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving PremarketMay 2, 2024 | msn.comWhy Aptevo Therapeutics Stock Is CrateringApril 11, 2024 | msn.comWhy Is Aptevo Therapeutics (APVO) Stock Down 56% Today?April 11, 2024 | investorplace.comAptevo Therapeutics Up 20% on Positive Interim Data for Tumor DrugMarch 7, 2024 | marketwatch.comAlligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4March 7, 2024 | finance.yahoo.comTrading was temporarily halted for "APVO" at 11:03 AM with a stated reason of "LULD pause."March 7, 2024 | marketbeat.comTrading was temporarily halted for "APVO" at 10:03 AM with a stated reason of "LULD pause." Trading set to resume at 11:03 AM. March 7, 2024 | marketbeat.comTrading was temporarily halted for "APVO" at 11:03 AM with a stated reason of "LULD pause."March 7, 2024 | marketbeat.comTrading was temporarily halted for "APVO" at 10:03 AM with a stated reason of "LULD pause."March 7, 2024 | marketbeat.comTrading was temporarily halted for "APVO" at 09:03 AM with a stated reason of "LULD pause."March 7, 2024 | marketbeat.comAptevo Therapeutics Inc (AP8N.BE)March 6, 2024 | ca.finance.yahoo.comAptevo Therapeutics enacts reverse stock split to meet Nasdaq requirementsMarch 6, 2024 | investing.comTrading was temporarily halted for "APVO" at 07:03 PM with a stated reason of "News pending."March 6, 2024 | marketbeat.comAPVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q4 2023March 5, 2024 | investorplace.comAptevo Therapeutics Inc (AP8N.DU)March 5, 2024 | finance.yahoo.comAptevo Therapeutics down 13%, will effect 1-for-44 reverse stock splitMarch 4, 2024 | msn.comPD-1 and PD-L1 Inhibitors Competitive Landscape Report 2024: Clinical Assessment of Over 200 Drugs Being Developed by More than 180 CompaniesMarch 1, 2024 | uk.finance.yahoo.comAptevo Therapeutics Inc (APVO)February 9, 2024 | investing.comAptevo Therapeutics Stockholders Approve Reverse SplitFebruary 7, 2024 | msn.comAptevo Therapeutics Inc. (APVO)January 24, 2024 | finance.yahoo.comAptevo Therapeutics files to sell up to 32.03M shares of common stock for holdersNovember 22, 2023 | msn.comAptevo Therapeutics GAAP EPS of -$0.50November 14, 2023 | msn.comAptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business UpdateNovember 14, 2023 | finance.yahoo.comAptevo Therapeutics: Aptevo to Present at Bio-Europe ConferenceNovember 1, 2023 | finanznachrichten.deAptevo to Present at Bio-Europe ConferenceNovember 1, 2023 | finance.yahoo.comWith New Cash Aptevo Goes It Alone on Prostate Drug, Shares Up - Biotech MoversOctober 21, 2023 | thestreet.comAptevo Therapeutics IncSeptember 26, 2023 | money.usnews.comAptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business UpdateAugust 10, 2023 | finance.yahoo.comAptevo Therapeutics Inc. Announces Closing of Previously Announced $5 Million Public OfferingAugust 4, 2023 | finance.yahoo.comAptevo Therapeutics (APVO) Price Target Increased by 24.14% to 18.36August 3, 2023 | msn.comWhy Aptevo Therapeutics Stock Is Getting ObliteratedAugust 2, 2023 | benzinga.comWhy Is Aptevo Therapeutics (APVO) Stock Down 33% Today?August 2, 2023 | investorplace.comAptevo Therapeutics down 25% after pricing $5M offeringAugust 2, 2023 | msn.comAptevo Therapeutics Inc. Announces Pricing of $5 Million Public OfferingAugust 2, 2023 | finance.yahoo.comAptevo Therapeutics: Aptevo Announces Positive Duration of Remission Data from Phase 1b Expansion Trial Evaluating the Bispecific APVO436 for AMLJuly 18, 2023 | finanznachrichten.deAptevo Therapeutics Stock Is Sinking Today - Here's WhyJuly 18, 2023 | benzinga.comAPVO - Aptevo Therapeutics Inc.June 29, 2023 | ca.finance.yahoo.comAptevo Therapeutics Reports 1Q23 Financial Results and Provides Business UpdateMay 11, 2023 | finance.yahoo.comAptevo Therapeutics Full Year 2022 Earnings: EPS Beats ExpectationsApril 1, 2023 | finance.yahoo.com Get Aptevo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide APVO Media Mentions By Week APVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APVO News Sentiment▼0.860.54▲Average Medical News Sentiment APVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APVO Articles This Week▼110▲APVO Articles Average Week Get Aptevo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CDT News JAGX News NKGN News MBIO News BCLI News RNAZ News EDSA News ATHE News BNOX News SNGX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APVO) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptevo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APVO Stock Alerts